Form 8-K - Current report:
SEC Accession No. 0001293971-24-000024
Filing Date
2024-08-14
Accepted
2024-08-14 07:03:21
Documents
17
Period of Report
2024-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20240813.htm   iXBRL 8-K 42255
2 EX-4.1 exhibit41warrant20240813.htm EX-4.1 103289
3 EX-4.2 exhibit42warrantamd20240813.htm EX-4.2 19981
4 EX-10.1 exhibit101lsaamend320240813.htm EX-10.1 78669
5 EX-99.1 exhibit99120240813.htm EX-99.1 31495
  Complete submission text file 0001293971-24-000024.txt   452099

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240813.xsd EX-101.SCH 1913
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240813_lab.xml EX-101.LAB 21880
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240813_pre.xml EX-101.PRE 12516
19 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240813_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 241204097
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)